Atea (AVIR) Q2 2026 Earnings Call Transcript
HCV regimen met non-inferiority with 8-week dosing for non-cirrhotic patients.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Atea (AVIR) Q2 2026 Earnings Call Transcript nasdaq.com